A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Clinical trial NCT03987958 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03987958
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-08
- Primary completion
- 2027-07-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.